Laboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary
Richárd Sinkó
Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary; János Szentágothai PhD School of Neurosciences, Semmelweis University, Budapest, Hungary
Péter Egri
Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary
Kristóf Rada
Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary
Yvette Ruska
Laboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary
The development of the brain, as well as mood and cognitive functions, are affected by thyroid hormone (TH) signaling. Neurons are the critical cellular target for TH action, with T3 regulating the expression of important neuronal gene sets. However, the steps involved in T3 signaling remain poorly known given that neurons express high levels of type 3 deiodinase (D3), which inactivates both T4 and T3. To investigate this mechanism, we used a compartmentalized microfluid device and identified a novel neuronal pathway of T3 transport and action that involves axonal T3 uptake into clathrin-dependent, endosomal/non-degradative lysosomes (NDLs). NDLs-containing T3 are retrogradely transported via microtubules, delivering T3 to the cell nucleus, and doubling the expression of a T3-responsive reporter gene. The NDLs also contain the monocarboxylate transporter 8 (Mct8) and D3, which transport and inactivate T3, respectively. Notwithstanding, T3 gets away from degradation because D3’s active center is in the cytosol. Moreover, we used a unique mouse system to show that T3 implanted in specific brain areas can trigger selective signaling in distant locations, as far as the contralateral hemisphere. These findings provide a pathway for L-T3 to reach neurons and resolve the paradox of T3 signaling in the brain amid high D3 activity.
